Sabyasachi Das has obtained his Ph. D degree from Vidyasagar University, India in 2015 in collaboration with Indian Institute of Technology (IIT), Kharagpur. He clinched 3rd position in M. Sc in Human Physiology with specialization in Microbiology and Immunology from Vidyasagar University in 2009.  He was also recipient of “Genetic Biotechnology, Senior research fellowship” from Council of Scientific and Industrial Research (CSIR), Govt. of India in 2013 and awarded JRF from Department of Biotechnology (DBT), Govt of India in 2009. After Ph D. he has completed two postdoctoral research from Calcutta School of Tropical Medicine, India in 2017. In the same year he joined as a guest faculty of molecular biology and immunology in Vidyasagar University. Furthermore, he joined department of Physiology, Lincoln University College Malaysia as senior lecture in 2018 where he became HOD of Physiology in 2019. In early 2021, he joined as an assistant professor of department of Physiology, Manipal University College Malaysia. Subsequently, in 2024 he joined department of Physiology, Faculty of Medicine, University Malaya as senior lecturer. His field of research are broadly on infectious disease, malaria, cancer, host immune interaction, nano drug delivery and development of early detection kit. He has extensively worked on molecular epidemiology and drug resistant pattern of Plasmodium. falciparum in different endemic zones of India. He has widely worked on understanding of chloroquine, and sulfadoxine-pyrimethamine resistance in P. falciparum and P. vivax. He was the first person to identify the failing of artemisinin combination therapy efficacy in eastern India and found the evidence of emergence of partial artemisinin resistant P. falciparum, thereby established a novel validate marker of artemisinin resistance. He has also extensively worked on nano mediated drug delivery against, parasite, bacteria and cancer cells. He has also developed novel early detection kit for malaria and dengue. He has also worked widely on immunity after covid vaccination.  Till date he has published more than 30 international research articles in different reputed journals including New England Journal of Medicine, Clinical infectious disease, International J of Antimicrobial Agent, Antimicrobial Agent and Chemotherapy, International J Parasitology: drug and drug resistance, International J of Pharmaceutics, Journal of biological macromolecule, European J of Pharmacology, Journal of Biological Inorganic Chemistry. He has one granted Malaysian Patent and filed one Indian Patent. He received prestigious INSA (Indian National Science Academy) Medal for Young Scientists for the year 2022 in health science (India’s highest recognition of promise, creativity and excellence in a young scientist). He also awarded “Young Scientist Award” in ‘Medical Science including Physiology’ by Indian Science Congress Association in 2017 for his commendable work in “Drug resistance malaria and nano drug development”. He has involved in different teaching activities for the students of different programs in University Malaya such as Bachelor of Biomedical Science, Bachelor of Medicine, Bachelor of Surgery (MBBS), and Bachelor of Dental Surgery. In his previous working place (MUCM) he was working as a Director of Research Management Centre (RMC) as well coordinator of mentor student project (MSB) for MBBS. He is the member of Royal Society of Biology (London). He is also the member of Malaysian Society of Pharmacology and Physiology (MSPP). He is also life member of The Physiological Society of Indian.

Professor Dr THONG Meow Keong studied medicine and trained in Paediatrics at the University of Malaya. He received genetics training in Singapore and was a Fellow in Clinical Genetics at the Women’s and Children’s Hospital, Adelaide and as a Senior Fellow at the renowned Murdoch Childrens Research Institute in Melbourne, Australia. He was recognized as the first board-certified clinical geneticist in Malaysia and helped established Clinical Genetics as a subspecialty in the National Specialist Register Malaysia. He established the first Genetics clinic with genetic counselling service at the University Hospital Kuala Lumpur in 1995 and headed the Genetics & Metabolism Unit at the Department of Paediatrics. He received a Doctorate in Medicine from University of Malaya in 2004, for research on the molecular genetics of beta thalassaemia and discovering the molecular basis of beta thalassaemia in the Kadazandusuns in Sabah.   Professor Thong was a Fulbright scholar at the Center for Diseases Control and Prevention (CDC) in Atlanta, USA and a past recipient of the 8th Royal College of Physicians of London and Academy of Medicine of Malaysia Annual Research Award, Australia-Malaysia Fellowship in Research Excellence, the Travel Award by the Asian Society for Pediatric Research Japan, University of Malaya Distinguished Service awards. He also won three gold medals in ITEX and Biotechnology Asia invention and innovation competitions. In 2019, he received the Minister of Education of Malaysia Award for Curriculum Design and Innovation as well as University of Malaya's Excellence Award for 'Distinguished Research in Science'. He was also the recipient for the prestigious American Society of Human Genetics Advocacy Award 2022. Professor Thong has published over 110 peer-reviewed publications on research work done on genetic disorders that hitherto have not been well documented in the various Asian subpopulations. He co-authored 8 books, including Handbook of Hospital Paediatrics (2nd edition), Problem-based Learning in Medical Sciences and Rare Journeys of Love and 15 book chapters, including a chapter in the prestigious Oxford monograph Genomics and Health in the Developing World and presented in many national and international conferences, including 180 proceedings and 6 keynote lectures. He worked closely with the Ministry of Health Malaysia in developing the counselling module for thalassaemia and other clinical practice guidelines. He collaborated with the World Health Organization and March of Dimes in preparing a document on management of birth defects and haemoglobinopathies as well as rare diseases. He was the lead author for two policy papers on 'Rare Diseases in Malaysia' written in conjunction with the Institute of Democracy and Economic Affairs (IDEAS) He was the past President of the Asia-Pacific Society of Human Genetics, founding Vice President of the Medical Genetics Society of Malaysia, Chairman of the Clinical Genetics sub-speciality committee of the National Specialist Register Malaysia, appointed member of the Education committee member in Paediatrics by the Malaysian Medical Council and President of the College of Paediatrics, Academy of Medicine of Malaysia. He was the Head, Department of Paediatrics, University of Malaya from 2009 – 2011 with the notable achievement of overseeing the successful transition of the Department of Paediatrics to the new Women’s and Children’s Health Complex of UMMC. He was also appointed as the founding Head, Genetic Medicine unit of the University Malaya Medial Centre. He was elected as a Fellow of Academy of Medicine of Malaysia, Academy of Medicine Singapore and Academy of Sciences Malaysia. He was elected a steering committee member of the Global Genomic Medicine Collaborative (G2MC) in 2022. Professor Thong is also a reviewer for international journal manuscripts, research grant applications as well as an examiner for national and international medical examinations in Sydney, Melbourne, Dhaka and Hong Kong. He co-authored the new Malaysian Paediatrics postgraduate curriculum in conjunction with the National Postgradaute Medical Curriculum Writing project. He organized the 10th Asia-Pacific Conference on Human Genetics and is the founding National Advisor to the Malaysian Rare Disorders Society since 2004 and a Trustee of the Rare Disease Alliance Foundation of Malaysia. He helped established the Genetic Counselling Society of Malaysia. He organised the first UM-Chinese University of Hong Kong Certificate Course in Clinical Genetics and Genomics at the University of Malaya. His current interests include delineation of rare disorders, preventive and curative strategies for genetic disorders, genetic counselling, inborn errors of metabolism. medical education and access to genetics and genomics services in developing countries. He is involved in gene therapy for patients and  other clinical trials for genetic diseases. He has obtained over 20 research grants and has international collaborations with renowned centres in Australia, Saudi Arabia, USA, Japan and Hong Kong. 

Dr. Rajenthyran Ayavoo is a senior lecturer in the Department of Management and Marketing at Universiti Malaya's Faculty of Business and Economics. With an extensive academic and industry background, he is highly regarded for his expertise in business management, particularly in the areas of technology, innovation, sustainability, and Environmental, Social, and Governance (ESG) practices. Dr. Raj holds a Ph.D. in Business Management from Alliance Manchester Business School, University of Manchester, UK, where his research concentrated on Technology Capabilities and Innovation Collaboration. His broad research portfolio spans technology transfer, inter-organizational collaboration, knowledge management, entrepreneurship, green innovation, sustainability, and collaborative R&D across technology and service industries. As an HRD Corp certified trainer, Dr. Raj has delivered training programs for both private companies and government agencies, including prominent organizations such as Infineon Technologies, Panasonic Malaysia, KWSP (Employees Provident Fund), and Kenanga Investment Bank Berhad. His deep expertise in technology management, innovation strategies, ESG practices, and business financing has positioned him as a trusted advisor for organizations looking to enhance their competitiveness in a rapidly evolving global marketplace. Dr. Raj’s reputation as an expert has also led to consulting roles with international and national agencies, including the Economic Planning Unit (EPU), Ministry of Economy, Institute for Capital Market Research Malaysia (ICMR), United Nations Global Compact (UNGC), and Organisation for Economic Co-operation and Development (OECD). These roles demonstrate his significant influence in shaping policies and strategies that promote sustainable growth and innovation. With over six years of industry experience working for major Malaysian financial institutions such as Eon Bank, Hong Leong Bank, AmBank, and CIMB Bank, Dr. Raj has a wealth of practical experience in areas like personal financing, SME financing, mortgages, and business loans. This hands-on industry experience complements his academic knowledge, enabling him to effectively bridge theoretical concepts with real-world applications. As a Doctoral Fellow at the Manchester Institute of Innovation Research (MIoIR), Dr. Raj continues to contribute to leading research in innovation and technology management. His blend of academic rigor, industry experience, and consulting expertise makes him a respected figure in business management, particularly in the areas of sustainability, ESG, and innovation-driven collaboration.